The recent news of former U.S. President Joe Biden’s advanced prostate cancer diagnosis brings attention to the ongoing fight against cancer.
Millions of people around the world are diagnosed with cancer each year including approximately 1.4 million prostate cancers and 500 000 pancreatic cancers.

💡 Breakthrough in nuclear medicine, exemplified by Pluvicto and Lutathera, is transforming the oncology landscape and bringing renewed hope to patients.

With MEDraysintell tracking nearly 250 RLT molecules in development, the future looks promising, not only for NET and prostate cancer, but also for a wide range of other solid tumors.

Medical advancements have the power to transform lives and rewrite destinies. Let us remember Steve Jobs, who passed away in 2011 from a pancreatic neuroendocrine tumor (NET).

🤝 Let’s continue working together to advance nuclear medicine, improve outcomes for patients around the world and offer hope for many.